A pilot phase II study of estradiol [TX-004HR] in postmenopausal women with vulvar and vaginal atrophy

Trial Profile

A pilot phase II study of estradiol [TX-004HR] in postmenopausal women with vulvar and vaginal atrophy

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Sep 2016

At a glance

  • Drugs Estradiol (Primary)
  • Indications Atrophic vaginitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Sep 2016 According to a TherapeuticsMD media release, data of this trial will be presented at annual meetings of the International Menopause Society (IMS) and the North American Menopause Society (NAMS), 2016.
    • 09 Mar 2015 Results published in TherapeuticsMD media release.
    • 09 Mar 2015 Results were presented at the Endocrine Society's 97th Annual Meeting & Expo in March 2015, according to a TherapeuticsMD media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top